Cadrenal Therapeutics, Inc. Common Stock
CVKD
$0.91-2.10%
End of day · as of Oct 10, 2026, 2:00 PM ET
Mkt cap
$20.22M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-0.26
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
1.12
Div yield
N/A
Sector
Healthcare
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a biotechnology company listed on US.
Use this CVKD research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full CVKD income, balance, and cash tables.
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a biotechnology company in the Healthcare sector.
Latest cached Cadrenal Therapeutics, Inc. Common Stock (CVKD) net income for FY2025 was -$13.2M. Statements: https://lician.com/financials/cvkd
Cadrenal Therapeutics, Inc. Common Stock (CVKD) market capitalization is $20.2M on the latest cached snapshot.
Cadrenal Therapeutics, Inc. Common Stock (CVKD) cached previous close $0.93; day range $0.90 – $0.97; volume 73,829. Session quote: https://lician.com/quote/cvkd
Cadrenal Therapeutics, Inc. Common Stock (CVKD) latest cached earnings event is "CVKD earnings" on Aug 17, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CVKD filing is 8-K · Oct 7, 2026. Filings: https://lician.com/sec/cvkd